Schultes Birgit C - Insider Non-Derivative Transactions at Intellia Therapeutics, Inc. (NTLA) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Oct 1, 2025, Schultes Birgit C's relationship to Intellia Therapeutics, Inc. (NTLA) is Officer (EVP, Chief Scientific Officer), and currently has 105,184 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other NTLA insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Schultes Birgit C - Insider Non-Derivative Transactions of NTLA Common Stock

Schultes Birgit C - Insider Non-Derivative Transactions at NTLA

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Oct 2, 2025	Sell -- (Common Stock)	31	17.38	105184
Mar 2, 2025	Acquisition -- (Common Stock)	37600	0	105215